uPAR-targeting small molecules are expected to act only in cells with high uPAR expression, a property almost exclusive to cancer cells; thus, new therapies based on these compounds are expected to be cancer cell specific and minimally toxic. The gene discussed is PLAUR; the disease is cancer.